首页> 中文期刊> 《中国中医药信息杂志》 >中药药氧疗法对脑梗死急性期增效作用的临床疗效观察

中药药氧疗法对脑梗死急性期增效作用的临床疗效观察

         

摘要

Objective To observe the clinical efficacy of synergism of TCM medicinal oxygen therapy in treating acute cerebral infarction.Methods Eighty cases were randomly divided into treatment group and control group, 40 cases in each group, and 1 case was lost in treatment group. Based on routine treatment, the control group was treated with low flow oxygen inhalation only, while the treatment group was treated with TCM medicinal oxygen therapy. The course of treatment was 2 weeks. The two groups were scored with National Institutes of Health Stroke Scale (NIHSS) and Stroke Symptom Scale of TCM (SSTCM) before and after the course to evaluate the therapeutic effect. Results The scores of NIHSS and SSTCM in both groups after the treatment were with statistical significance (P<0.05). There was no statistical difference in the scores of NIHSS between two groups after the treatment (P=0.10). There were statistical difference in the scores of SSTCM between two groups after the treatment (P<0.05). The clinically curative effect rate in treatment group was76.9% (30/39), which was superior to that of 60.0% (24/40) in the control group, with statistical significance (P=0.27).Conclusion TCM medicinal oxygen therapy can improve the neurological deficit and enhance the efficacy.%目的:观察中药药氧疗法对脑梗死急性期患者增效作用的临床疗效。方法将80例患者随机分为观察组和对照组各40例,其中观察组脱落1例。在常规治疗基础上,对照组给予单纯低流量氧气吸入治疗。观察组给予中药药氧疗法,2组分别于治疗前及治疗2周后采用美国国立卫生研究院卒中量表(NIHSS)、中风中医症征积分表(SSTCM)进行评分,评价临床疗效。结果治疗后2组NIHSS评分、SSTCM积分与治疗前相比差异均有统计学意义(P<0.05),治疗后2组NIHSS评分组间比较差异无统计学意义(P=0.10),治疗后SSTCM组间比较差异有统计学意义(P<0.05)。观察组临床总有效率为76.9%(30/39),对照组为60.0%(24/40),2组比较差异有统计学意义(P=0.27)。结论中药药氧疗法有助于改善患者的神经功能缺损,增强治疗效果。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号